相关实验视频

Updated: Jun 12, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

探索骨质肉瘤中线粒体自失调的研究:它对预后和向治疗的影响

Xiangpan Kong^1,2, Dawei He^1,2, Quan Wang^3,2

¹Department of Urology, Children's Hospital of Chongqing Medical University.

Combinatorial chemistry & high throughput screening

|September 19, 2024

概括

骨髓瘤患者EPHA3的下调与转移风险的增加相关,可能是通过损害线粒体自. 这一发现为骨髓瘤进展和治疗目标提供了新的见解.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

骨髓瘤是一种主要的骨恶性瘤,具有显著的转移潜力.
线粒体,受损线粒体的选择性降解,在细胞平衡和疾病中起作用.
了解骨髓瘤转移中的基因表达对于改善患者的治疗结果至关重要.

研究的目的:

在骨髓瘤患者中识别差异表达的髓相关基因.
探索骨髓瘤转移背后的分子机制.
开发一个用于骨髓瘤预后的预测模型.

主要方法:

从转移性和非转移性骨髓瘤患者的微阵列数据的分析.
利用NetworkAnalyst进行差异性基因查和线性基因交叉.
使用随机森林和LASSO回归开发了一个风险预测模型.
进行了功能丰富,蛋白与蛋白相互作用 (PPI) 网络分析,免疫测试和体外实验.

主要成果:

确定了七个差异表达的基因,并开发了一个强大的风险预测模型 (AUC=0.886).
PPI和功能丰富分析阐明了关键的分子通路.
免疫试验表明,转移性和非转移性组之间存在不同的免疫微环境.
在转移性骨肉瘤中证明了显著的EPHA3下调;抑制EPHA3增强了细胞的增殖和迁移.

结论:

EPHA3的下调与骨髓瘤中线粒体自功能障碍有关.
减少EPHA3的表达可能会促进骨髓瘤转移.
EPHA3 是一个潜在的治疗点,可以缓解骨髓瘤的进展.

关键词:

在EPHA3.3中使用.骨质肉瘤骨质肉瘤是什么生物信息学研究研究线粒细胞衰变 (mitophagy) 是一种神经衰变的过程.

更多相关视频

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Autophagy

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...